Role of cytokines in experimental and human visceral leishmaniasis
Visceral Leishmaniasis (VL) is the most fatal form of disease leishmaniasis. To date, there
are no effective prophylactic measures and therapeutics available against VL. Recently, new …
are no effective prophylactic measures and therapeutics available against VL. Recently, new …
Animal models for the study of leishmaniasis immunology
EN Loría-Cervera, FJ Andrade-Narváez - Revista do Instituto de …, 2014 - SciELO Brasil
Leishmaniasis remains a major public health problem worldwide and is classified as
Category I by the TDR/WHO, mainly due to the absence of control. Many experimental …
Category I by the TDR/WHO, mainly due to the absence of control. Many experimental …
Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach
Visceral leishmaniasis (VL) is a fatal form of leishmaniasis which affects 70 countries,
worldwide. Increasing drug resistance, HIV co-infection, and poor health system require …
worldwide. Increasing drug resistance, HIV co-infection, and poor health system require …
Vaccine candidates for leishmaniasis: a review
R Nagill, S Kaur - International immunopharmacology, 2011 - Elsevier
Leishmaniasis is a diverse group of clinical syndromes caused by protozoan parasites of the
genus Leishmania. The clinical manifestation of the disease varies from self-limiting …
genus Leishmania. The clinical manifestation of the disease varies from self-limiting …
Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis
A Khamesipour, Y Dowlati, A Asilian… - Vaccine, 2005 - Elsevier
To establish the safety and reproducibility of live challenge with Leishmania major, a single
frozen stabilate was used in two open, single-arm leishmanization (LZ) trials. A total of 42 …
frozen stabilate was used in two open, single-arm leishmanization (LZ) trials. A total of 42 …
[PDF][PDF] Leishmaniasis vaccine candidates for development: a global overview
A vaccine against different forms of leishmaniasis should be feasible considering the wealth
of information on genetics and biology of the parasite, clinical and experimental immunology …
of information on genetics and biology of the parasite, clinical and experimental immunology …
Leishmania vaccines: progress and problems
L Kedzierski, Y Zhu, E Handman - Parasitology, 2006 - cambridge.org
Leishmania are protozoan parasites spread by a sandfly insect vector and causing a
spectrum of diseases collectively known as leishmaniasis. The disease is a significant …
spectrum of diseases collectively known as leishmaniasis. The disease is a significant …
Visceral leishmaniasis: experimental models for drug discovery
S Gupta - Indian Journal of Medical Research, 2011 - journals.lww.com
Visceral leishmaniasis (VL) or kala-azar is a chronic protozoan infection in humans
associated with significant global morbidity and mortality. The causative agent is a …
associated with significant global morbidity and mortality. The causative agent is a …
Animal models for vaccine studies for visceral leishmaniasis
Visceral leishmaniases (VL) or kala-azar is the most dreaded and devastating amongst the
various forms of leishmaniases. The disease, though localized in certain areas only, has …
various forms of leishmaniases. The disease, though localized in certain areas only, has …
[HTML][HTML] The diverse applications of recombinant BCG-based vaccines to target infectious diseases other than tuberculosis: an overview
E Mouhoub, P Domenech, M Ndao… - Frontiers in …, 2021 - frontiersin.org
Live attenuated Bacillus Calmette-Guérin (BCG) is the world's most widely used vaccine
which is mainly administered for its protection against tuberculosis (TB), particularly in young …
which is mainly administered for its protection against tuberculosis (TB), particularly in young …